Valeant Drug Discounts Haven’t Materialized, Hospitals Say

Updated on
  • ‘We’ve seen no reduction in cost,’ hospital executive says
  • Valeant says discounts are available to all hospitals

Months after Valeant Pharmaceuticals International Inc. said it would make discounts available to U.S. hospitals for two high-priced heart drugs, some medical centers say they have yet to see a cent of savings.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.